Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Morphine antibody

ELISA Host: Mouse Monoclonal 2F11 unconjugated
Catalog No. ABIN723276
  • Target See all Morphine products
    Morphine
    Reactivity
    Please inquire
    Host
    • 14
    • 3
    • 3
    • 1
    Mouse
    Clonality
    • 14
    • 7
    Monoclonal
    Conjugate
    • 12
    • 3
    • 3
    • 1
    • 1
    • 1
    This Morphine antibody is un-conjugated
    Application
    • 20
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Cross-Reactivity (Details)
    Morphine
    Purification
    Purified by Protein G.
    Immunogen
    KLH conjugated Morphine molecular modified
    Clone
    2F11
    Isotype
    IgG
  • Application Notes
    ELISA 1:500-1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Expiry Date
    12 months
  • Target
    Morphine
    Abstract
    Morphine Products
    Target Type
    Chemical
    Background

    Synonyms: Morphine 6.

    Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

You are here:
Support